Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rory D de Vries

Showing results (1-10 of 165) with videos related to

Pageof 17
Sort By:
Msphere|March 28, 2020
mSphere of Influence: Understanding Virus-Host Interactions Requires a Multifaceted ApproachRory D de Vries
Signal Transduction and Targeted Therapy|October 7, 2020
SARS-CoV-2-specific T-cells in unexposed humans: presence of cross-reactive memory cells does not equal protective immunityRory D de Vries
The Lancet. Infectious Diseases|December 23, 2023
Self-amplifying RNA vaccines against antigenically distinct SARS-CoV-2 variantsSander Herfst, Rory D de Vries
Human Vaccines & Immunotherapeutics|July 26, 2016
Viral vector-based influenza vaccinesRory D de Vries, Guus F Rimmelzwaan
The Lancet. Infectious Diseases|September 8, 2022
Evaluating novel COVID-19 vaccines in the current chapter of the pandemicCorine H GeurtsvanKessel, Rory D de Vries
Expert Review of Vaccines|August 24, 2012
Evaluating measles vaccines: can we assess cellular immunity?Rory D de Vries, Rik L de Swart
Cell Host & Microbe|January 12, 2023
Antibodies face the challenge against human respiratory syncytial virusRory D de Vries, Rik L de Swart
Vaccines|July 26, 2018
Avian Influenza A Virus Pandemic Preparedness and Vaccine DevelopmentRory D de Vries, Sander Herfst, Mathilde Richard
Plos Pathogens|December 19, 2014
Measles immune suppression: functional impairment or numbers game?Rory D de Vries, Rik L de Swart
The Lancet. Infectious Diseases|October 26, 2024
Steps towards licensure of self-amplifying RNA vaccinesMaarten F Wilbrink, Sander Herfst, Rory D de Vries
Pageof 17

Showing results (1-10 of 165) with videos related to

Sort By:
Pageof 17
Msphere|March 28, 2020
mSphere of Influence: Understanding Virus-Host Interactions Requires a Multifaceted ApproachRory D de Vries
Signal Transduction and Targeted Therapy|October 7, 2020
SARS-CoV-2-specific T-cells in unexposed humans: presence of cross-reactive memory cells does not equal protective immunityRory D de Vries
The Lancet. Infectious Diseases|December 23, 2023
Self-amplifying RNA vaccines against antigenically distinct SARS-CoV-2 variantsSander Herfst, Rory D de Vries
Human Vaccines & Immunotherapeutics|July 26, 2016
Viral vector-based influenza vaccinesRory D de Vries, Guus F Rimmelzwaan
The Lancet. Infectious Diseases|September 8, 2022
Evaluating novel COVID-19 vaccines in the current chapter of the pandemicCorine H GeurtsvanKessel, Rory D de Vries
Expert Review of Vaccines|August 24, 2012
Evaluating measles vaccines: can we assess cellular immunity?Rory D de Vries, Rik L de Swart
Cell Host & Microbe|January 12, 2023
Antibodies face the challenge against human respiratory syncytial virusRory D de Vries, Rik L de Swart
Vaccines|July 26, 2018
Avian Influenza A Virus Pandemic Preparedness and Vaccine DevelopmentRory D de Vries, Sander Herfst, Mathilde Richard
Plos Pathogens|December 19, 2014
Measles immune suppression: functional impairment or numbers game?Rory D de Vries, Rik L de Swart
The Lancet. Infectious Diseases|October 26, 2024
Steps towards licensure of self-amplifying RNA vaccinesMaarten F Wilbrink, Sander Herfst, Rory D de Vries
Pageof 17